Home › Companies › DENALI THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and DENALI THERAPEUTICS INC.’s Form 8-K, filed May 31, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 31, 2024: 5 items on DENALI THERAPEUTICS INC.’s Form 8-K, filed May 31, 2024: 3 elected · 2 approved.
Significant dissent: 1 director (25.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore DENALI THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DENALI THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 31, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jay Flatley | 108,094,205 | -- | -- | 2,149,100 | 8,072,151 | 98% | Elected | — |
| Elect Director: Mac Tessier-Lavigne, Ph.D. | 82,215,374 | -- | -- | 28,027,931 | 8,072,151 | 75% | Elected | — |
| Elect Director: Nancy A. Thornberry | 108,270,582 | -- | -- | 1,972,723 | 8,072,151 | 98% | Elected | — |
| 2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 117,978,800 | 297,039 | 39,617 | -- | -- | 99.7% | Approved | — |
| 3. Advisory Vote to Approve Executive Compensation | 101,612,037 | 8,587,858 | 43,410 | -- | 8,072,151 | 92% | Approved | — |
Source: DENALI THERAPEUTICS INC., Form 8-K, filed with the SEC on May 31, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
241 asset managers disclosed a vote on at least one DENALI THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jay Flatley
DENALI THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jay Flatley”): 108,094,205 for, 2,149,100 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the following nominees was elected to serve as a Class I director, to hold office until the Company's 2027 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 67 asset managers below reported 44,758,381 for, 1,141,996 withheld, 18,833 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,640,380 | 0 | 0 | 4,065 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 960,117 | Withhold |
| BNY Mellon | 951,619 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 197,782 | 0 | 0 | 132,920 | Mixed |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 146,221 | 0 | 0 | 7,432 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 102,110 | 0 | 15,441 | 0 | Mixed |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Marc Tessier-Lavigne, Ph.D.
DENALI THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mac Tessier-Lavigne, Ph.D.”): 82,215,374 for, 28,027,931 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the following nominees was elected to serve as a Class I director, to hold office until the Company's 2027 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal.”
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 67 asset managers below reported 36,552,123 for, 9,192,671 withheld, 174,416 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 5,914,332 | Withhold |
| State Street | 3,591,746 | 0 | 0 | 52,699 | For |
| Fidelity | 3,568,561 | 0 | 0 | 67,393 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 960,117 | Withhold |
| BNY Mellon | 944,587 | 0 | 0 | 7,032 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 264 | 0 | 0 | 385,554 | Withhold |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 12,669 | 0 | 0 | 318,033 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 277,830 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 201,173 | Withhold |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 99,000 | 0 | 0 | 54,653 | Mixed |
| Voya | 0 | 0 | 0 | 145,063 | Withhold |
| Thrivent | 0 | 0 | 0 | 130,979 | Withhold |
| Jackson National | 27,597 | 0 | 89,954 | 0 | Mixed |
| John Hancock | 67,319 | 0 | 44,091 | 0 | Mixed |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Nancy Thornberry
DENALI THERAPEUTICS INC.’s own tally for this item (“Elect Director: Nancy A. Thornberry”): 108,270,582 for, 1,972,723 withheld, per its Form 8-K filed May 31, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Each of the following nominees was elected to serve as a Class I director, to hold office until the Company's 2027 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 67 asset managers below reported 44,758,381 for, 1,141,996 withheld, 18,833 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,640,380 | 0 | 0 | 4,065 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 960,117 | Withhold |
| BNY Mellon | 951,619 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 197,782 | 0 | 0 | 132,920 | Mixed |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 146,221 | 0 | 0 | 7,432 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 102,110 | 0 | 15,441 | 0 | Mixed |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 93.7% for (June 1, 2023 meeting) ▼ 1.5 pts
Description as filed by funds: Advisory Vote to Ratify Named Executive Officers' Compensation
DENALI THERAPEUTICS INC.’s own tally for this item (“3. Advisory Vote to Approve Executive Compensation”): 101,612,037 for, 8,587,858 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Advisory Vote to Approve Executive Compensation The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,635,776 | 8,669 | 0 | 0 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 0 | 2,909,528 | 0 | 0 | Against |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 960,117 | 0 | 0 | 0 | For |
| BNY Mellon | 7,032 | 944,587 | 0 | 0 | Against |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Artisan | 476,563 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 330,702 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 153,653 | 0 | 0 | 0 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 117,551 | 0 | 0 | 0 | For |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Fund voting reports, all 68 managers: 42,248,744 for, 3,951,916 against, 19,493 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO LTD | 9,237,808 | 0 | 0 | 0 | For |
| Wellington | 7,887,309 | 0 | 0 | 0 | For |
| State Street | 5,940,204 | 8,826 | 0 | 0 | For |
| Temasek Holdings (Private) Ltd | 5,706,345 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 3,812,615 | 0 | 0 | 0 | For |
| BlackRock | 3,720,377 | 27,519 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 3,731,695 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 0 | 2,909,528 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 2,749,789 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,135,401 | 0 | 0 | 0 | For |
| UBS | 18,544 | 1,678,892 | 0 | 0 | Against |
| Camber Capital Management LP | 1,500,000 | 0 | 0 | 0 | For |
| Flagship Pioneering Inc. | 1,364,516 | 0 | 0 | 0 | For |
| Fidelity | 1,232,617 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 0 | 1,160,650 | 0 | 0 | Against |
| Charles Schwab | 1,047,165 | 0 | 0 | 0 | For |
| Yiheng Capital Management, L.P. | 967,504 | 0 | 0 | 0 | For |
| Northern Trust | 860,474 | 78 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 638,662 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 636,838 | 0 | 0 | Against |
| Cercano Management LLC | 625,000 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 548,857 | 0 | 0 | Against |
| Woodline Partners LP | 527,217 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 510,285 | 0 | 0 | 0 | For |
Institutional-manager reports, all 196 managers: 61,483,021 for, 7,733,596 against, 95 abstained, 4,200 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.7% Approved · of votes cast
Prior year: 99.8% for (June 1, 2023 meeting) ▼ 0.1 pts
Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024
DENALI THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, ”): 117,978,800 for, 297,039 against — passed, per its Form 8-K filed May 31, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based on the following results of voting:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 68 asset managers below reported 45,875,590 for, 24,192 against, 19,493 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,393,648 | 0 | 0 | 0 | For |
| BlackRock | 5,914,332 | 0 | 0 | 0 | For |
| State Street | 3,638,222 | 6,223 | 0 | 0 | For |
| Fidelity | 3,635,954 | 0 | 0 | 0 | For |
| Capital Group | 2,909,528 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,508,585 | 0 | 0 | 0 | For |
| Charles Schwab | 1,047,120 | 0 | 0 | 0 | For |
| Dimensional | 960,117 | 0 | 0 | 0 | For |
| BNY Mellon | 951,619 | 0 | 0 | 0 | For |
| Aberdeen | 516,019 | 0 | 0 | 0 | For |
| TIAA | 504,281 | 0 | 0 | 0 | For |
| Principal | 385,818 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 380,297 | 0 | 0 | 0 | For |
| Equitable | 330,702 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 277,830 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 201,173 | 0 | 0 | 0 | For |
| Artisan | 187,455 | 0 | 0 | 0 | For |
| Hartford | 173,517 | 0 | 0 | 0 | For |
| Lincoln Financial | 153,653 | 0 | 0 | 0 | For |
| Voya | 145,063 | 0 | 0 | 0 | For |
| Thrivent | 130,979 | 0 | 0 | 0 | For |
| Jackson National | 117,551 | 0 | 0 | 0 | For |
| John Hancock | 111,410 | 0 | 0 | 0 | For |
| Russell Investments | 106,873 | 0 | 0 | 0 | For |
| Northwestern Mutual | 101,689 | 0 | 0 | 0 | For |
Showing the 25 largest of 68 asset managers. All 68 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 142,512,856 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 14.31% |
| 2 | BlackRock | 4.15% |
| 3 | State Street | 2.56% |
| 4 | Fidelity | 2.55% |
| 5 | Capital Group | 2.04% |
| 6 | T. Rowe Price | 1.06% |
| 7 | Charles Schwab | 0.73% |
| 8 | Dimensional | 0.67% |
| 9 | BNY Mellon | 0.67% |
| 10 | Aberdeen | 0.36% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAILLIE GIFFORD & CO LTD | 6.48% |
| 2 | Wellington | 5.53% |
| 3 | State Street | 4.17% |
| 4 | Temasek Holdings (Private) Ltd | 4.00% |
| 5 | BAILLIE GIFFORD OVERSEAS LTD | 2.68% |
| 6 | BlackRock | 2.63% |
| 7 | BAKER BROS. ADVISORS LP | 2.62% |
| 8 | Capital Research Global Investors | 2.04% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.93% |
| 10 | T. Rowe Price | 1.50% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Baillie Gifford & Co | 14,260,724 | 10.01% | Proxy statement (DEF 14A), proxy filed April 18, 2024 |
| Biogen | 12,751,365 | 8.95% | Proxy statement (DEF 14A), proxy filed April 18, 2024 |
| BlackRock | 12,289,626 | 8.62% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 11,992,918 | 8.42% | Form 13F, quarter ended March 31, 2024 |
| Wellington Management | 8,269,949 | 5.80% | Form 13F, quarter ended March 31, 2024 |
| Wellington | 7,378,977 | 5.18% | Proxy statement (DEF 14A), proxy filed April 18, 2024 |
| Biogen MA Inc. | 7,155,243 | 5.02% | Schedule 13G, filed November 7, 2024 |
| FMR (Fidelity) | 6,340,316 | 4.45% | Form 13F, quarter ended March 31, 2024 |
| State Street | 6,323,872 | 4.44% | Form 13F, quarter ended March 31, 2024 |
| Douglas K. Bratton | 5,750,882 | 4.04% | Schedule 13G, filed February 13, 2024 |
Percentages above are of 142,512,856 shares outstanding, as reported by DENALI THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At DENALI THERAPEUTICS INC.'s shareholder meeting held May 31, 2024, in the 2023-2024 proxy season, 241 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,540 separate fund positions. On the most widely held item on that ballot — Advisory Vote to Ratify Named Executive Officers' Compensation — DENALI THERAPEUTICS INC.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: DENALI THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 31, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DENALI THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
DENALI THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “DENALI THERAPEUTICS (DNLI) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/denali-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.